CSPC Pharmaceutical Group Limited (FRA:CVG)

CSPC Pharmaceutical Group Statistics

Total Valuation

FRA:CVG has a market cap or net worth of EUR 8.08 billion. The enterprise value is 7.23 billion.

Market Cap	8.08B
Enterprise Value	7.23B

Important Dates

The next estimated earnings date is Friday, May 23, 2025.

Earnings Date	May 23, 2025
Ex-Dividend Date	Jun 4, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-1.14%
Shares Change (QoQ)	-1.22%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	7.82B

Valuation Ratios

The trailing PE ratio is 14.10.

PE Ratio	14.10
Forward PE	n/a
PS Ratio	2.10
PB Ratio	1.80
P/TBV Ratio	2.07
P/FCF Ratio	24.22
P/OCF Ratio	13.46
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.14, with an EV/FCF ratio of 21.67.

EV / Earnings	12.62
EV / Sales	2.06
EV / EBITDA	9.14
EV / EBIT	11.31
EV / FCF	21.67

Financial Position

The company has a current ratio of 2.27, with a Debt / Equity ratio of 0.01.

Current Ratio	2.27
Quick Ratio	1.95
Debt / Equity	0.01
Debt / EBITDA	0.08
Debt / FCF	0.20
Interest Coverage	122.87

Financial Efficiency

Return on equity (ROE) is 12.60% and return on invested capital (ROIC) is 9.57%.

Return on Equity (ROE)	12.60%
Return on Assets (ROA)	7.40%
Return on Invested Capital (ROIC)	9.57%
Return on Capital Employed (ROCE)	15.44%
Revenue Per Employee	179,385
Profits Per Employee	26,763
Employee Count	21,400
Asset Turnover	0.64
Inventory Turnover	2.78

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -11.11% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-11.11%
50-Day Moving Average	0.60
200-Day Moving Average	0.61
Relative Strength Index (RSI)	60.88
Average Volume (20 Days)	6,085

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:CVG had revenue of EUR 3.84 billion and earned 572.73 million in profits. Earnings per share was 0.05.

Revenue	3.84B
Gross Profit	2.69B
Operating Income	710.11M
Pretax Income	738.24M
Net Income	572.73M
EBITDA	853.69M
EBIT	710.11M
Earnings Per Share (EPS)	0.05

Balance Sheet

The company has 1.21 billion in cash and 67.14 million in debt, giving a net cash position of 1.14 billion.

Cash & Cash Equivalents	1.21B
Total Debt	67.14M
Net Cash	1.14B
Net Cash Per Share	n/a
Equity (Book Value)	4.48B
Book Value Per Share	0.37
Working Capital	1.62B

Cash Flow

In the last 12 months, operating cash flow was 600.08 million and capital expenditures -266.68 million, giving a free cash flow of 333.40 million.

Operating Cash Flow	600.08M
Capital Expenditures	-266.68M
Free Cash Flow	333.40M
FCF Per Share	n/a

Margins

Gross margin is 69.97%, with operating and profit margins of 18.50% and 14.92%.

Gross Margin	69.97%
Operating Margin	18.50%
Pretax Margin	19.23%
Profit Margin	14.92%
EBITDA Margin	22.24%
EBIT Margin	18.50%
FCF Margin	8.68%

Dividends & Yields

This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 5.22%.

Dividend Per Share	0.04
Dividend Yield	5.22%
Dividend Growth (YoY)	19.27%
Years of Dividend Growth	3
Payout Ratio	74.72%
Buyback Yield	1.14%
Shareholder Yield	6.35%
Earnings Yield	7.09%
FCF Yield	4.13%

Stock Splits

The last stock split was on October 15, 2020. It was a forward split with a ratio of 1.6.

Last Split Date	Oct 15, 2020
Split Type	Forward
Split Ratio	1.6

Scores

FRA:CVG has an Altman Z-Score of 5.87.

Altman Z-Score	5.87
Piotroski F-Score	n/a